# Computed tomography angiography in the diagnosis of non-ST-elevation myocardial infarction: redefining our first line of defense

**Authors:** Yvonne J.M. van Cauteren, Marie-Julie D.K. Lemmens, Sebastiaan C.A.M. Bekkers, Bas L.J.H. Kietselaer, Jordi Heijman, Ralph A.L.J. Theunissen, Braim Rahel, Talitha Voorn, Sander M.J. van Kuijk, Robin Nijveldt, Kevin Vernooy, Joachim E. Wildberger, Casper Mihl, Martijn W. Smulders

PMC · DOI: 10.1016/j.ijcha.2025.101690 · International Journal of Cardiology. Heart & Vasculature · 2025-05-02

## TL;DR

This study shows that computed tomography angiography (CTA) can accurately diagnose non-ST-elevation myocardial infarction (NSTEMI) and help avoid unnecessary invasive procedures.

## Contribution

The study evaluates CTA's diagnostic accuracy for NSTEMI and identifies key CTA parameters associated with the condition.

## Key findings

- CTA had 95% sensitivity and 65% specificity for diagnosing NSTEMI.
- Patients with NSTEMI had significantly higher Agatston scores and more high-risk plaque features.
- Combining CTA parameters did not improve diagnostic accuracy beyond CAD-RADS alone.

## Abstract

Approximately one-third of patients with suspected non-ST-elevation myocardial infarction (NSTEMI) have non-obstructive coronary artery disease. Low-risk patients might benefit from early non-invasive diagnostic testing that can appropriately select those without obstructive coronary artery disease and prevent unnecessary invasive coronary angiography (ICA). The purpose of this study is to evaluate the diagnostic value of computed tomography angiography (CTA) in suspected NSTEMI.

Patients with clinically suspected type 1 NSTEMI were included. In case ICA was indicated, CTA was performed prior to ICA. The accuracy of CTA to diagnose NSTEMI, assigned by an adjudicated final diagnosis committee, was investigated.

Of the 66 included patients, 40 (61%) were diagnosed with NSTEMI. CAD-RADS ≥ 3 (i.e. stenosis ≥50%) had a sensitivity of 95% (95%CI 83–99%), a specificity of 65% (95%CI 44–83%) and an overall accuracy of 83% (95%CI 72–91%). The Agatston score was significantly different between patients with and without NSTEMI (404 [IQR 132–883] and 31 [IQR 0–163], respectively, p < 0.001). Nineteen patients (29%) met the criteria of ≥2 high-risk plaque (HRP) features, which was more often present in patients with NSTEMI compared to those without NSTEMI (43% and 8%, respectively, p = 0.002). Combining all CTA parameters (CAD-RADS ≥ 3, Agatston score >1.000 and ≥2 HRP features) did not improve the diagnostic accuracy compared with CAD-RADS alone.

CTA accurately diagnoses NSTEMI in patients with acute chest pain and elevated high-sensitivity cardiac troponin T levels. Patients with NSTEMI more often presented with CAD-RADS ≥ 3, Agatston score >1.000 and HRP features.

## Linked entities

- **Diseases:** coronary artery disease (MONDO:0005010)

## Full-text entities

- **Diseases:** non-obstructive coronary artery disease (MESH:D000088442), NSTEMI (MESH:D000072658), chest pain (MESH:D002637), coronary artery disease (MESH:D003324)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12124661/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12124661/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12124661/full.md

---
Source: https://tomesphere.com/paper/PMC12124661